Patent loss weighs on MRNA
Moderna is drifting moderately lower as a court struck its US government license defense in the Northwestern patent case, a direct legal setback, and this offsets the positive narrative from its announced Nasdaq-100 inclusion.
Sources: https://www.reuters.com/legal/government/moderna-loses-us-government-license-defense-northwestern-patent-case-2026-10-01/,
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works